{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:43:47Z","timestamp":1740149027155,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s12325-023-02630-x","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T08:02:31Z","timestamp":1695196951000},"page":"4999-5015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8203-4738","authenticated-orcid":false,"given":"Kyle","family":"Hayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7989-3187","authenticated-orcid":false,"given":"John","family":"Niewoehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9276-9710","authenticated-orcid":false,"given":"J. Bradford","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4846-5229","authenticated-orcid":false,"given":"Nathaniel","family":"Downes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0506-7004","authenticated-orcid":false,"given":"Ella","family":"Hagopian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6179-8494","authenticated-orcid":false,"given":"Izzy","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-740X","authenticated-orcid":false,"given":"George J.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"2630_CR1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on sarcoidosis","year":"1999","unstructured":"Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"2630_CR2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014;383:1155\u201367.","journal-title":"Lancet"},{"key":"2630_CR3","first-page":"840","volume":"93","author":"N Soto-Gomez","year":"2016","unstructured":"Soto-Gomez N, Peters JI, Nambiar AM. Diagnosis and management of sarcoidosis. Am Fam Physician. 2016;93:840\u20138.","journal-title":"Am Fam Physician"},{"key":"2630_CR4","first-page":"312","volume":"70","author":"JJ Wu","year":"2004","unstructured":"Wu JJ, Schiff KR. Sarcoidosis. Am Fam Physician. 2004;70:312\u201322.","journal-title":"Am Fam Physician"},{"issue":"4","key":"2630_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/jcm9041081","volume":"9","author":"R Jain","year":"2020","unstructured":"Jain R, Yadav D, Puranik N, Guleria R, Jin JO. Sarcoidosis: causes, diagnosis, clinical features, and treatments. J Clin Med. 2020;9(4):1081.","journal-title":"J Clin Med"},{"key":"2630_CR6","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman RP, Field S, Costabel U, et al. Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc. 2016;13:1244\u201352.","journal-title":"Ann Am Thorac Soc"},{"key":"2630_CR7","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153\u201365.","journal-title":"N Engl J Med"},{"key":"2630_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","volume":"132","author":"NA Khan","year":"2017","unstructured":"Khan NA, Donatelli CV, Tonelli AR, et al. Toxicity risk from glucocorticoids in sarcoidosis patients. Respir Med. 2017;132:9\u201314.","journal-title":"Respir Med"},{"key":"2630_CR9","doi-asserted-by":"publisher","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","volume":"58","author":"RP Baughman","year":"2021","unstructured":"Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58:2004079.","journal-title":"Eur Respir J"},{"key":"2630_CR10","unstructured":"Acthar Gel (repository corticotropin injection) [prescribing information]. Bridgewater, NJ: Mallinckrodt ARD LLC."},{"key":"2630_CR11","doi-asserted-by":"publisher","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","volume":"29","author":"FF Rahaghi","year":"2020","unstructured":"Rahaghi FF, Baughman RP, Saketkoo LA, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev. 2020;29:190146.","journal-title":"Eur Respir Rev"},{"key":"2630_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fneur.2013.00021","volume":"4","author":"AP Ross","year":"2013","unstructured":"Ross AP, Ben-Zacharia A, Harris C, et al. Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone. Front Neurol. 2013;4:21.","journal-title":"Front Neurol"},{"key":"2630_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.rmed.2015.11.007","volume":"110","author":"RP Baughman","year":"2016","unstructured":"Baughman RP, Barney JB, O\u2019Hare L, Lower EE. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. Respir Med. 2016;110:66\u201372.","journal-title":"Respir Med"},{"issue":"3","key":"2630_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","volume":"195","author":"RP Baughman","year":"2017","unstructured":"Baughman RP, Sweiss N, Keijsers R, et al. Repository corticotropin for chronic pulmonary sarcoidosis. Lung. 2017;195(3):313\u201322.","journal-title":"Lung"},{"key":"2630_CR15","doi-asserted-by":"publisher","first-page":"175346661988812","DOI":"10.1177\/1753466619888127","volume":"13","author":"I Chopra","year":"2019","unstructured":"Chopra I, Qin Y, Kranyak J, et al. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records. Therap Adv Respir Dis. 2019;13:175346661988812.","journal-title":"Therap Adv Respir Dis"},{"key":"2630_CR16","unstructured":"Yasir M, Goyal A, Sonthalia S. Corticosteroid adverse effects. 2022 Jul 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022."},{"issue":"4","key":"2630_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","volume":"33","author":"AL Buchman","year":"2001","unstructured":"Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33(4):289\u201394.","journal-title":"J Clin Gastroenterol"},{"key":"2630_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/JAA.S176026","volume":"11","author":"DB Price","year":"2018","unstructured":"Price DB, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193\u2013204 (Crossref. PubMed).","journal-title":"J Asthma Allergy"},{"key":"2630_CR19","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/03007995.2018.1474090","volume":"34","author":"JB Rice","year":"2018","unstructured":"Rice JB, White AG, Johnson M, et al. Quantitative characterization of the relationship between levels of extended corticosteroid use and related adverse events in a US population. Curr Med Res Opin. 2018;34:1519\u201327 (Crossref. PubMed).","journal-title":"Curr Med Res Opin"},{"key":"2630_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/13696998.2018.1474750","volume":"21","author":"JB Rice","year":"2018","unstructured":"Rice JB, White AG, Johnson M, et al. Healthcare resource use and cost associated with varying dosages of extended corticosteroid exposure in a US population. J Med Econ. 2018;21:846\u201352 (Crossref. PubMed).","journal-title":"J Med Econ"},{"issue":"5","key":"2630_CR21","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1183\/09031936.00156314","volume":"44","author":"DR Moller","year":"2014","unstructured":"Moller DR. Negative clinical trials in sarcoidosis: failed therapies or flawed study design? Eur Respir J. 2014;44(5):1123\u20136. https:\/\/doi.org\/10.1183\/09031936.00156314.","journal-title":"Eur Respir J"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02630-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02630-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02630-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T10:42:08Z","timestamp":1697020928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02630-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2630"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02630-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"2 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kyle Hayes, John Niewoehner, and George J. Wan are employees of Mallinckrodt Pharmaceuticals, which provided research funding to Analysis Group (employer of J. Bradford Rice, Nathaniel Downes, Ella Hagopian, and Izzy Ma).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously collected, de-identified data and did not explicitly precipitate human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}